Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 43

Cracking the code of p53 fragility: Why the genome guardian is prone to failure

The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumors.

A longstanding mystery has been why p53—unlike its closely related paralogs p63 and p73—is so prone to misfolding and forming toxic aggregates. A new study published in Communication Chemistry now provides a detailed molecular explanation for this vulnerability.

Led by researchers at the Federal University of Rio de Janeiro (UFRJ), the D’Or Institute for Research and Education (IDOR), the University of Campinas (Unicamp), and the Federal University of Tri ngulo Mineiro (UFTM), the team mapped the protein’s internal landscape at residue-level resolution using high-pressure NMR spectroscopy, fluorescence spectroscopy, and molecular dynamics simulations.

Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous side effects that have long limited immune-based treatments for glioblastoma, one of the deadliest and most treatment-resistant brain cancers.

The therapy works by reprogramming CAR-T cells to release immune-stimulating proteins, called IL-12 and DR-18, that activate the body’s own immune system, strengthening the overall anti-cancer response. In mouse models, the approach improved tumor control, including against cancers made up of mixed cell populations that often escape therapies.

Researchers also found that pairing the treatment with a second CAR-T strategy targeting VEGF, a protein that drives abnormal blood vessel growth and contributes to swelling in glioblastoma, helped reduce side effects while preserving strong anti-tumor activity.

Prefusion-stabilized Hantaan virus glycoprotein nucleic acid vaccine elicits potent neutralizing antibody responses via germinal center activation

This study presents a prefusion-stabilized vaccine candidate against Hantaan virus. The DNA and mRNA-LNP formats induce lasting neutralizing immunity in female mice, highlighting a promising advance in vaccine development.

Stelarc on Transhumanism: We Are in a Time of Circulating Flesh!

“We are in a time of circulating flesh.”

Stelarc said that to me 13 years ago. In 2026, it reads less like art criticism and more like a status report.

He had grown an ear on his arm. He had hung himself from hooks 25 times. He had let strangers on the internet choreograph his muscles through electrical stimulation, his body remote-controlled across continents.

Most people called it spectacle. I think it was inquiry.

Because long before deepfakes, before voice cloning, before AI agents wearing our faces, was already asking the question we now cannot avoid:

Where does the body end and the network begin?

Continue reading “Stelarc on Transhumanism: We Are in a Time of Circulating Flesh!” | >

This ‘living plastic’ activates and self-care destructs on command

Many plastic products are designed to be used only once, yet the material itself lasts for years. But a new strategy is addressing this problem by creating products that self-destruct on command, known as living plastics. These materials incorporate activatable, plastic-degrading microbes alongside the polymers. One team reporting in ACS Applied Polymer Materials used two bacterial strains that worked together and completely broke down the material within just six days, without making microplastics.

Why scientists are rethinking plastics Zhuojun Dai, a corresponding author on the paper, explains that “the realization that traditional plastics persist for centuries, while many applications, like packaging, are short-lived, led us to ask: Could we build degradation directly into the material’s life cycle?”

Many microbes can break long polymeric chains into smaller pieces using enzymes. Because plastics are polymers, these enzymes or the microbes that make them could be incorporated into living plastics.

Glucose nanoparticles help CBD cross the blood-brain barrier

Breakthrough in brain medicine: a new way to deliver CBD!

Cannabidiol (CBD) has incredible potential to fight brain inflammation, but it has always faced a major roadblock: it struggles to dissolve and cross the blood-brain barrier. Researchers have just developed an ingenious solution using glucose-coated nanoparticles to get CBD exactly where it needs to go.

Here’s why it’s a game-changer: 🔬 Sneaky Delivery: The glucose coating helps the particles “hitch a ride” on the brain’s natural glucose transporters, successfully smuggling the CBD across the blood-brain barrier. 🎯 Smart Release: Once inside the brain, the nanoparticles target immune cells (microglia) and only release the CBD when they detect the chemical stress of active inflammation. 🐁 Promising Results: In mouse models of Parkinson’s disease and depression, this new delivery method drastically reduced inflammation, protected neurons, and improved behavioral recovery compared to standard CBD.

This targeted approach could be a massive step forward in treating chronic neuroinflammatory diseases! 🧬✨

Studty.

Glucose-coated nanoparticles carry CBD across the blood-brain barrier, trigger release in inflamed tissue, and reduce neuroinflammatory signs in mice.

Continue reading “Glucose nanoparticles help CBD cross the blood-brain barrier” | >

The Many Faces of Nonthrombotic Pulmonary Artery Embolism

Not all pulmonary emboli are thrombotic. NTPE spans septic, tumor, fat, air, and iatrogenic causes, often mimicking PE but requiring different management. Recognizing key imaging clues + clinical context is critical for timely, lifesaving diagnosis.

Nonthrombotic pulmonary artery embolism (NTPE) involves occlusion of pulmonary arteries by nonthrombotic material, such as septic emboli, tumor cells, fat, air, or foreign substances. NTPE is less common than thrombotic pulmonary embolism (PE) and may be misdiagnosed as PE. Although the clinical manifestation mimics that of PE, NTPE has distinct pathophysiologic mechanisms that necessitate different management. Diagnosis requires a high index of clinical suspicion and knowledge of imaging findings. The authors provide an overview of the various causes of NTPE, including infectious, neoplastic, iatrogenic or exogenous, and miscellaneous entities, and highlight their key imaging findings. Early and accurate diagnosis is essential for appropriate management.

©RSNA, 2026

AI is starting to beat doctors at making correct diagnoses

Researchers show that a type of AI known as a large language model often outperformed physicians at diagnosing complex and potentially life-threatening conditions, including decreased blood flow to the heart, even in the fast-moving stages of real ER care when information is limited.

In early ER cases, the model identified the correct or a very close diagnosis in about 67% of cases, compared with roughly 50% to 55% for physicians. And the technology is only getting better.

If you walk into an emergency room (ER) in 10 years, you’ll encounter a new type of caregiver: an artificial intelligence (AI) system designed to get you a diagnosis faster and help your care team make more informed decisions. While you sit in the waiting room, you’ll be hooked up to a blood pressure cuff that’s constantly and autonomously monitored. All the while, an AI agent will be listening in while you and your doctor talk about your symptoms, ready to flag any mistakes your physician makes or suggest next steps.

This vision of AI-assisted emergency health care may soon be reality. In a new study, researchers show that a type of AI known as a large language model (LLM) often outperformed physicians at diagnosing complex and potentially life-threatening conditions, including decreased blood flow to the heart, even in the fast-moving stages of real ER care when information is limited, they report today in Science. In early ER cases, the model identified the correct or a very close diagnosis in about 67% of cases, compared with roughly 50% to 55% for physicians. And the technology is only getting better.

“Evaluating AI in medicine demands both depth and breadth across different clinical tasks and settings,” and these authors were able to incorporate both in this study, says Shreya Johri, a computer scientist at the Dana-Farber Cancer Institute who was uninvolved with the new research. Still, she notes, wide adoption of these AI systems in health care will hinge on knowing the contexts in which they’re most reliable.

Biomimetic Microfibers for Myelin-Enhancer Screening and Neural Regeneration

Roles of lysosomal small-molecule transporters in metabolism and signaling

Small-molecule transporters of the lysosomal membrane export lysosomal catabolites for reuse in cell metabolism.

These transporters often show substrate promiscuity and, conversely, a given metabolite is often exported through distinct transport routes and sometimes in different states (e.g., single amino acids versus dipeptides).

Some lysosomal transporters import metabolites into the lumen. The combination of importers and exporters can create small-molecule shuttles across the lysosomal membrane, which regulate the lumen state.

Some lysosomal transporters participate in intracellular signaling cascades. sciencenewshighlights ScienceMission https://www.cell.com/trends/cell-biology/fulltext/S0962-8924(25)00222-3 https://sciencemission.com/lysosomal-small-molecule-transporters

Remyelination requires the precise wrapping of axons by oligodendrocyte processes, a critical step for restoring neural circuit function. However, a lack of quantitative systems that recapitulate axonal geometry and chemistry has limited mechanistic and pharmacological insights into myelin wrapping. Here, we present a bioengineered microfiber platform that mimics neurite architecture and surface chemistry, enabling high-content quantification of oligodendrocyte wrapping. Through compound screening, we identified dimemorfan, a clinically used sigma-1 receptor agonist, as a potent enhancer of myelin wrapping. Dimemorfan treatment accelerated remyelination and functional recovery in demyelinated mice and promoted myelin wrapping by human induced pluripotent stem cell (iPSC)-derived oligodendrocytes.

Continue reading “Biomimetic Microfibers for Myelin-Enhancer Screening and Neural Regeneration” | >

How an HIV/AIDS tragedy spurred human evolution

Researchers show that a type of AI known as a large language model often outperformed physicians at diagnosing complex and potentially life-threatening conditions, including decreased blood flow to the heart, even in the fast-moving stages of real ER care when information is limited.

In early ER cases, the model identified the correct or a very close diagnosis in about 67% of cases, compared with roughly 50% to 55% for physicians. And the technology is only getting better.

Before antiretroviral (ARV) drugs started to become widely available in KwaZulu-Natal in 2005, there was “kind of the perfect storm,” with several unusual factors coalescing to drive a devastating epidemic, says Philip Goulder, an immunologist at the University of Oxford who led the study, which appears today in the Proceedings of the National Academy of Sciences. HIV had made few inroads into South Africa until the early 1990s, when an epidemic exploded in the heterosexual population, infecting about 40% of pregnant women in KwaZulu-Natal. (That astonishingly high prevalence persists today.) Because of a mix of genetics, limited health care, and possibly the viral subtype in circulation, infected people developed AIDS—when the destruction of the immune system threatens survival—exceptionally quickly, within about 4.5 years versus 10 years in North America.

Other studies have shown how infectious diseases, including malaria and tuberculosis, have altered the human genome. But those changes took thousands of years. “That’s what is quite exciting about this: You can see how rapidly evolution actually can occur,” Goulder says.

Similar evolutionary forces may have been at work in North America and Europe, but they are more difficult to see—and less likely to affect future generations. HIV prevalence in those regions is below 1%, and the hardest-hit group is men who have sex with men. “They are generally not a population that’s leaving behind as many offspring,” Worobey notes.

/* */